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Bovine brain coated vesicles display free calcium-dependent phospholipase C activity. Gpp(NH)p and GTPyS inhibited phospholipase C at 
nanomolar concentrations. Increasing concentrations of Gpp(NW)p and GTPrS reversed the inhibitory effects and stimulated phospholipase C 
activity. Preincubation of coated vesicles with pertussis toxin blocked the poorly-hydrolyzable GTP-analogs’ inhibitory effects on phospholipase 
C. These data indicate that guanine nucleotides exert a dual regulatory control of phospholipase C in coated vesicles and that the inhibitory pathway 
is mediated by-a pertissis toxin-s&sit&e G-protein. 
1. INTRODUCTION 
Phospholipase C (PLC) 
Coated vesicle; Phospholipase C; G-protein; Guanine nucleotide 
is a virtually ubiquitous 
membrane-associated transducing enzyme. Its activa- 
tion through hormones and/or neurotransmitters leads 
to the breakdown of phosphatidylinositol phosphates, 
generating second messengers such as inositol 
phosphates and diacylglycerol [l]. Inositol phosphates 
trigger calcium release from intracellular compartments 
[a], and diacylglycerol stimulates calcium-dependent 
protein kinase C [3]. Activation of PLC by hormones 
and neurotransmitters has been shown to be mediated 
by guanine nucleotide binding proteins [4,5]. In the 
same cells, this process seems to be pertussis toxin-sensi- 
tive [6,7] while in others it is not [8,9]. The G-proteins 
G, [ 101 and members of the G, family [11,12], which are 
not substrates for pertussis toxin, have been proposed 
to be candidates for the G-protein that mediates pertus- 
sis toxin-insensitive stimulation of PLC. On the other 
hand, several studies with membranes [13] and per- 
meabilized cells [14,15] have suggested that PLC is also 
under the control of a G-protein-mediated inhibitory 
pathway. In analogy with the adenylate cyclase, which 
is regulated by two different G-proteins, G, (stimu- 
Abbreviations; Gpp(NI-I)p, guanyl-5-yl-imidodiphosphate; GTPyS, 
guanosine 5’.(y-thio)triphosphate; Ptd Ins P2, phosphatidylinositol 
4,S-bisphosphate; PLC, phospholipase C. 
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latory) and Gi (inhibitory), and in spite of the lack of 
a precise characterization of the G-proteins responsible 
for stimulation and inhibition of PLC, the terms Gp, 
and Gpi have been assigned. 
Recently, evidence for the presence of the com- 
ponents of the adenylate cyclase system such as re- 
ceptors that mediate stimulation [16], receptors that 
mediate inhibition [ 17,181, the catalytic activity and G- 
proteins [l&19] have been described in coated vesicles. 
These are subcellular organelles involved in endocytotic 
and exocytotic protein trafficking within the cell [20]. 
The presence of transducing systems in compartments 
besides plasma membrane opens several questions 
about signal transduction, desensitization and protein 
trafficking. In the present report, the presence of PEG 
and its dual regulatory control by putative stimulatory 
and inhibitory G-proteins in coated vesicles are inves- 
tigated. 
2. MATERIAL AND METHODS 
2.1. Maleriois 
Phosphatidyl [2-‘H]inositol 4,5-bisphosphate ([lH]Ptd Ins Pz) was 
purchased from Amersham. Pertussis toxin was from List Biological 
Laboratories. Non-hydrolysable guanine nucleotides were purchased 
from Boehringer-Mannheim. All other reagents were of analytical 
grade. 
2.2. Prepararion of metnbranes and coaled vesicles 
Plasma membranes were obtained from bovine brain as described 
by Olsen et al. [2l] and Recasens et al. [22]. Coated vesicles were 
obtained by Shephacryl S 1000 gel filtration as described by Bar-Zvi 
and Branton [23] and modified by Gonzjlez-Calero et al. [18]. This 
method yields a coated-vesicle preparation with minimal cross-con- 
tamination with other subcellular fractions as deduced by marker 
enzyme activities and electron microscopy [ 181. 
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on the free calcium concentration in a similar manner 
to that described in plasma membranes from several 
tissues [25,28]. Maximal activity was observed at 80 @vl 
free calcium, both in the presence and in the absence of 
GTPyS. Reduction of the free calcium concemtration 
below 0.3 PM or an increase up to 1 mM led to a loss 
of activity. Taken into the account hat the PLC activity 
found in the coated vesicles fraction is similar to that 
found in the plasma membrane fraction (Table I) and 
that cross-contamination i  the coated-vesicle fraction 
is minimal [IS], these data clearly indicate the presence 
of PLC in coated vesicles. 
As PLC was shown to be stimulated through G- 
proteins in plasma membranes from different cell types 
[4,5], the effects of guanine nucleotides on PLC have 
been investigated incoated vesicIes. Table II shows that 
poorly hydrolysable GTP analogs stimulated PLC, 
6 6 4 3 
suggesting that a G-protein also mediates the activation 
-Log eeo=*‘14, M 
of this enzyme in coated vesicles. This effect seems to 
be specific, since ATP did not stimulate PLC. As in the 
Fig. 1. Effects of free calcium concentration on phospholipase C 
activity. Coated vesicles (lo-15 fig protein) were incubated with 
r3H]Ptd Ins P* for 10 min at 37°C as doscribed in section 2 with (0) 
or without (@ 100,~M GTPyS. Data values are means 1 SEM of three 
separate experiments performed in duplicate. 
case- of adenylate cyclase, a G-protein-mediated inhib- 
itory pathway also has been described to regulate PLC 
activity [] 3-153. This pathway was shown to be sensitive 
to lower concentrations of GTP-analogs [13] and in- 
2.3. Pizospholipase C assay 
Phospholipasc C in coated vesicles and plasma membranes was 
assayed in the presence of exogenous l’H]Ptd Ins Pt as described by 
Tiger et al. [24]. Ptd Ins Pz was dried under an Nz stream, dissolved 
in 40 mM sodium deoxicholate, 40 mM Tris-HCl pH 6.8, sonicated 
and used immediately for assay as described earlier [24]. Phos- 
pholipase C assay was carried out for 10 min at 37”C, incubating 15 
pmol [‘H]Ptd Ins P, (I 5 000-20 000 cpm) with or without lo-15gg of 
coated vesicles or plasma membrane protein in 100 ~1 of buffer con- 
taining 40 mM sodium deoxicholate, 100 mM NaCl, 40 snM LiCI, 1 
mM EDTA and 50 mM Tris-NC1 pl-I 6.8 and the indicated concentra- 
tions of fret calcium. Free Ca*+ concentrations were set using a Ca2- 
EGTA buffer system as described bJ Hcrrero et al. [25]. The incuba- 
tion was terminated by the addition of 360 pm of chloroform/me- 
thanol/HCI (1:2:0.2, v/v) and putting the tubes on ice. After addition 
of 120 ,uI 2 M KCI and 160 ~1 of chloroform. The upper phase was 
used to evaluate Ptd Ins P, hydrolysis as described earlier [24]. 
Table I 
Phospholipase C activity in plasma membranes and coated vesicles. 
Fraction PLC activity 
(pmoYmg prot x min) 
Basal Gpp(NH)p-stimula- 
ted 
Plasma membranes 3.68 + 0.22 6.95 -I- 0.33 
Coated vesicles 2.87 zk 0.19 5.17 It 0.21 
- 
10-l 5 pg of plasma membranes or coated vesicles protein were incuba- 
ted with 15 pmol of [‘H]Ptd Ins P, as described in section 2. Data 
values are means -I- SEM of five separate experiments performed in 
triplicate. 
2.4. Pert&s toxin ADPhbosyIation 
Coated vesicles were incubated with preactivated pertussis toxin (1 
pg/lOO ,ug protein) or vehicle for 30 min at 30°C as described by 
Malbon et al. [26] in a final volume of 1 ml 100 mM phosphate buffer 
pH 7.5 containing 1 mM EDTA, 2 mM MgC&, 2 mM NAD’, 1 mM 
ATP, 100pM GTP and protease inhibitars (Ieupeptin SOC(g/ml, apro- 
tinin 50 @ml), After incubation, samples were centrifugated at 
100 000 x g for 30 min and coated vesicles were washed and re- 
suspended in isolation buffer, prior to PLC assay. 
2.5. Protein cletern~ination 
Protein concentration was determined by the method of Lowry et 
al. [27], using bovine serum albumin as a standard. 
Table I1 
Effects of nucleotides on phospholipase C activity in coated vesicles. 
Nucleotide PLC activity (% basal) 
Control 100% 
GPPWUP 169 -I- 19% 
GTPyS 193 I+ 46% 
ATP 99f 1% 
3. RESULTS AND DISCUSSlION 
Coated vesicles, isolated from bovine brain, display 
PLC activity. Fig. 1 shows that this activity is dependent 
Phospholipase C activity was measured in the absence and in the 
oresence of 1OOuM of the indicated nucleotides as described in section 
2. Control activity was 3.21) -C 0.39 pmoVmg prot x min. Data values 




9 7 5 9 7 5 
- Log etX-P’CS3 , wl - ksg cGppNt=4~3,M 
Fig. 2. Effects of poorly hydrolysable GTP analcgs on phosphol&se C activity. Coated vesicles (IO-I 5yg OF protein) were incubated in the presence 
of 300 nM free calcium and the presence of the indicated concentrations of GTPyS (A) and Gpp(NH)p (B) as described in section 2. Basal 
phospholipase activity was 3.28 t 0.39 pmol/mE prot x min. Data values are means If: SEM of three separate experiments performed in duplicate. 
*P <: 0.05; **P c 0.02; significantly different from basal activity. 
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dependent of calcium mobilization or cAMP generation 
[14,15]. In Fig. 2 it can be observed that nmolar con- 
centrations of Gpp(NH)p and GTPyS significantly in- 
hibit PLC activity, while pmo1a.r concentrations reverse 
the inhibitory effects of poorly hydrolysable GTP 
analogs. A stimulation of 50% and 40% was observed 
at 10 ,uM Gpp(NH)p and 10 PM GTPyS, respectively. 
These data. show that PLC in coated vesicles behaves in 
a similar fashion to that described in m.embranes [13] 
and clearly suggest a dual, G-protein-mediated, regu- 
latory control of PLC in this subcellular fraction. 
Stimulation [4,5] and inhibition [13-151 of PLC have 
been described to be pertussis toxin-sensitive processes, 
depending on the cell type studied. In order to inves- 
tigate whether guanine nucleotide stimulation and/or 
inhibition of PLC are sensitive to pertussis toxin, the 
effects of GTP analogs were tested in coated vesicles 
preincubated with or without preactivated pertussis 
toxin. Fig. 3 shows that the inhibitory effects of 
Gpp(NH)p and GTPyS on PLC at nmolar concentra- 
tions were suppressed by pertussis toxin, suggesting that 
the putative G-protein that mediates inhibition in 
coated vesicles is a substrate for pertussis toxin. Th.e fact 
that basal PLC activity in coated vesicles incubated with 
pertussis toxin is higher than in controls (Fig. 3, legend) 
also supports the idea that the inhibitory pathway is 
mediated by a pertussis toxin-sensitive G-protein. In 
agreement with these data, the presence of pertussis 
toxin substrates has been demonstrated in coated 
24 
vesicles [19], On the other hand, Fig. 3 also shows that 
pertussis toxin does not affect the stimulation of PLC 
caused by GTP analogs. These data support the pres- 
ence of a pertussis toxin-insensitive G-protein coupled 
to PLC in a stimulatory manner. Due to the existence 
of a growing family of G-proteins, substrates [29,3OJ (or 
not [3 11) for pertussis toxin-catalized ADP-ribosylation, 
as well as the existence of several forms of PLC [32], 
identifica.tion of which G-protein couples to which PLC 
isoform has not yet been resolved. Nevertheless, 
recently, evidence suggesting that Gq is the G-protein 
which mediates pertussis toxin-insensitive stimulation 
of PLC activity has been shown [33,34]. 
Pn the present report, besides the presence of PLC 
activity in coated vesicles isolated from bovine brain, a 
dual regulatory effect of GTP-analogs on this signal- 
transducing enzyme has been described in this subcel- 
lular fraction. Thus, as described in membranes [13] and 
in an analogous fashion to the adenylate cyclase, in 
coated vesicles, PLC seems to be under the control of 
both stimulatory and inhibitory pathways mediated by 
stimulatory and inhibitory G-proteins, respectively. 
The physiological meaning of the presence of mem- 
brane-associated transducing enzymes such as ade- 
nylate cyclase or PLC in coated vesicles remains to be 
elucidated. The presence of transducing enzymes in 
coated vesicles might be understood in the context of 
desensitization. Thus, as receptors, G-proteins which 
have been shown to be present in subcellular fractions 
Volume 290, number I,2 FEES LETTERS September 199 1 
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-Log %GppNHp3,M 
Fig. 3. Pertussis toxin effects on poorly hydrolysable GTP analogs modulation of phospholipase C activity. Coated vesicles were incubated with 
peeactivated pertussis toxin (1 &lOO pg protein (0, 0) or vehicle (e. q ) for 30 min at 30°C prior to PLC activity assay as described in section 
2. Basal PLC activities were 2.4 + 0.67 and 4.23 + 0.98 pmol/mg prot x min, in the absence and in the presence of pertussis toxin, respectively. 
Data values are means + SEM of three separate experiments performed in duplicate. *P < 0.05: **P c 0.02; significantly different from its basal 
activity. 
after agonist-receptor interactions [35], transducing en- 
zymes might also be internalized. Another possibility 
would be the continuation of its transducing function 
next to the plasma membrane. This possibility has been 
suggested earlier [35] and in this sense, internalization 
of middle t has been shown to be necessary to produce 
transformation [36]. Further studies to identify the G- 
proteins present in coated vesicles and their putative 
role in signal transduction, protein trafficking and/or 
desensitization will be needed. 
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